377 related articles for article (PubMed ID: 22946758)
1. Haemophilia B: current pharmacotherapy and future directions.
Franchini M; Frattini F; Crestani S; Bonfanti C
Expert Opin Pharmacother; 2012 Oct; 13(14):2053-63. PubMed ID: 22946758
[TBL] [Abstract][Full Text] [Related]
2. Current management of hemophilia B: recommendations, complications and emerging issues.
Franchini M
Expert Rev Hematol; 2014 Oct; 7(5):573-81. PubMed ID: 25112898
[TBL] [Abstract][Full Text] [Related]
3. Emerging drugs for hemophilia B.
Mannucci PM; Franchini M
Expert Opin Emerg Drugs; 2014 Sep; 19(3):407-14. PubMed ID: 25098797
[TBL] [Abstract][Full Text] [Related]
4. Recombinant factor IX for clinical and research use.
Monahan PE; Di Paola J
Semin Thromb Hemost; 2010 Jul; 36(5):498-509. PubMed ID: 20632248
[TBL] [Abstract][Full Text] [Related]
5. BAX326 (recombinant coagulation factor IX) for the treatment and prophylaxis of hemophilia B.
Windyga J; Abbuehl BE; Hafeman AE
Expert Rev Hematol; 2014 Jun; 7(3):333-42. PubMed ID: 24832133
[TBL] [Abstract][Full Text] [Related]
6. Recombinant FIXFc: a novel therapy for the royal disease?
Valentino LA
Expert Opin Biol Ther; 2011 Oct; 11(10):1361-8. PubMed ID: 21780945
[TBL] [Abstract][Full Text] [Related]
7. Expression and characterization of a novel human recombinant factor IX molecule with enhanced in vitro and in vivo clotting activity.
Perot E; Enjolras N; Le Quellec S; Indalecio A; Girard J; Negrier C; Dargaud Y
Thromb Res; 2015 May; 135(5):1017-24. PubMed ID: 25795563
[TBL] [Abstract][Full Text] [Related]
8. Optimizing the treatment of haemophilia B: laboratory and clinical perspectives.
Aledort LM
Haemophilia; 2010 Jul; 16 Suppl 6():1-2. PubMed ID: 20561350
[TBL] [Abstract][Full Text] [Related]
9. Current factor IX replacement options for hemophilia B and the challenges ahead.
Franchini M; Zaffanello M; Focosi D
Expert Opin Pharmacother; 2023 Apr; 24(6):729-736. PubMed ID: 36963373
[TBL] [Abstract][Full Text] [Related]
10. The history of hemophilia.
Franchini M; Mannucci PM
Semin Thromb Hemost; 2014 Jul; 40(5):571-6. PubMed ID: 24911674
[TBL] [Abstract][Full Text] [Related]
11. GlycoPEGylated recombinant factor IX for hemophilia B in context.
Santagostino E; Mancuso ME
Drug Des Devel Ther; 2018; 12():2933-2943. PubMed ID: 30254423
[TBL] [Abstract][Full Text] [Related]
12. Haemophilia B: impact on patients and economic burden of disease.
Gater A; Thomson TA; Strandberg-Larsen M
Thromb Haemost; 2011 Sep; 106(3):398-404. PubMed ID: 21833450
[TBL] [Abstract][Full Text] [Related]
13. Half-life extension through albumin fusion technologies.
Schulte S
Thromb Res; 2009 Dec; 124 Suppl 2():S6-8. PubMed ID: 20109653
[TBL] [Abstract][Full Text] [Related]
14. The role of Rixubis™ in the treatment of hemophilia B.
Valentino LA
Immunotherapy; 2014; 6(4):381-94. PubMed ID: 24815779
[TBL] [Abstract][Full Text] [Related]
15. A retrospective study to describe the incidence of moderate to severe allergic reactions to factor IX in subjects with haemophilia B.
Recht M; Pollmann H; Tagliaferri A; Musso R; Janco R; Neuman WR
Haemophilia; 2011 May; 17(3):494-9. PubMed ID: 21518148
[TBL] [Abstract][Full Text] [Related]
16. The safety of pharmacologic options for the treatment of persons with hemophilia.
Franchini M; Mannucci PM
Expert Opin Drug Saf; 2016 Oct; 15(10):1391-400. PubMed ID: 27367551
[TBL] [Abstract][Full Text] [Related]
17. Trenonacog alfa for prophylaxis, on-demand and perioperative management of hemophilia B.
Brennan Y; Curnow J; Favaloro EJ
Expert Opin Biol Ther; 2018 Jan; 18(1):95-100. PubMed ID: 29172774
[TBL] [Abstract][Full Text] [Related]
18. The natural history of mild haemophilia: a 30-year single centre experience.
Tagliaferri A; Di Perna C; Riccardi F; Pattacini C; Rivolta GF; Franchini M
Haemophilia; 2012 Mar; 18(2):166-74. PubMed ID: 21771207
[TBL] [Abstract][Full Text] [Related]
19. Monitoring once-weekly recombinant factor IX prophylaxis in hemophilia B with thrombin generation assay and factor IX activity.
Nummi V; Jouppila A; Lassila R
Int J Lab Hematol; 2017 Aug; 39(4):359-368. PubMed ID: 28406575
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive care for hemophilia and other inherited bleeding disorders.
Page D
Transfus Apher Sci; 2019 Oct; 58(5):565-568. PubMed ID: 31427262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
